{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T02:44:34Z","timestamp":1787885074231,"version":"build-2784847793"},"reference-count":92,"publisher":"BMFH Press","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020]]},"DOI":"10.12938\/bmfh.19-023","type":"journal-article","created":{"date-parts":[[2019,12,24]],"date-time":"2019-12-24T22:04:06Z","timestamp":1577225046000},"page":"23-32","source":"Crossref","is-referenced-by-count":329,"title":["Interaction of the microbiota with the human body in health and diseases"],"prefix":"10.12938","volume":"39","author":[{"given":"Safaa","family":"ALTVE\u015e","sequence":"first","affiliation":[{"name":"Department of Medical Biology, Meram Faculty of Medicine, Necmettin Erbakan University, Konya, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hatice K\u00fcbra","family":"YILDIZ","sequence":"additional","affiliation":[{"name":"Department of Medical Biology, Meram Faculty of Medicine, Necmettin Erbakan University, Konya, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hasibe Cingilli","family":"VURAL","sequence":"additional","affiliation":[{"name":"Department of Medical Biology, Meram Faculty of Medicine, Necmettin Erbakan University, Konya, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"5076","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Marchesi JR, Ravel J. 2015. The vocabulary of microbiome research: a proposal. Microbiome 3: 31.","DOI":"10.1186\/s40168-015-0094-5"},{"key":"2","unstructured":"2. Leung TLF, Poulin R. 2008. Parasitism, commensalism, and mutualism: exploring the many shades of symbioses. Vie Milieu 58: 107\u2013115."},{"key":"3","doi-asserted-by":"publisher","unstructured":"3. Belkaid Y, Hand TW. 2014. Role of the microbiota in immunity and inflammation. Cell 157: 121\u2013141.","DOI":"10.1016\/j.cell.2014.03.011"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Flandroy L, Poutahidis T, Berg G, Clarke G, Dao MC, Decaestecker E, Furman E, Haahtela T, Massart S, Plovier H, Sanz Y, Rook G. 2018. The impact of human activities and lifestyles on the interlinked microbiota and health of humans and of ecosystems. Sci Total Environ 627: 1018\u20131038.","DOI":"10.1016\/j.scitotenv.2018.01.288"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Islam SU. 2016. Clinical uses of probiotics. Medicine (Baltimore) 95: e2658.","DOI":"10.1097\/MD.0000000000002658"},{"key":"6","doi-asserted-by":"publisher","unstructured":"6. Davani-Davari D, Negahdaripour M, Karimzadeh I, Seifan M, Mohkam M, Masoumi SJ, Berenjian A, Ghasemi Y. 2019. Prebiotics: definition, types, sources, mechanisms, and clinical applications. Foods 8: 92.","DOI":"10.3390\/foods8030092"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Wang B, Yao M, Lv L, Ling Z, Li L. 2017. The human microbiota in health and disease. Engineering (Beijing) 3: 71\u201382.","DOI":"10.1016\/J.ENG.2017.01.008"},{"key":"8","unstructured":"8. Milosevic I, Vujovic A, Barac A, Djelic M, Korac M, Radovanovic Spurnic A, Gmizic I, Stevanovic O, Djordjevic V, Lekic N, Russo E, Amedei A. 2019. Gut-liver axis, gut microbiota, and its modulation in the management of liver diseases: a review of the literature. Int J Mol Sci 20: 395."},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Peterson J, Garges S, Giovanni M, McInnes P, Wang L, Schloss JA, Bonazzi V, McEwen JE, Wetterstrand KA, Deal C, Baker CC, Di Francesco V, Howcroft TK, Karp RW, Lunsford RD, Wellington CR, Belachew T, Wright M, Giblin C, David H, Mills M, Salomon R, Mullins C, Akolkar B, Begg L, Davis C, Grandison L, Humble M, Khalsa J, Little AR, Peavy H, Pontzer C, Portnoy M, Sayre MH, Starke-Reed P, Zakhari S, Read J, Watson B, Guyer M, NIH HMP Working Group. 2009. The NIH human microbiome project. Genome Res 19: 2317\u20132323.","DOI":"10.1101\/gr.096651.109"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Raoult D. 2008. Obesity pandemics and the modification of digestive bacterial flora. Eur J Clin Microbiol Infect Dis 27: 631\u2013634.","DOI":"10.1007\/s10096-008-0490-x"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Sekirov I, Russell SL, Antunes LC, Finlay BB. 2010. Gut microbiota in health and disease. Physiol Rev 90: 859\u2013904.","DOI":"10.1152\/physrev.00045.2009"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. LeBlanc JG, Lai\u00f1o JE, del Valle MJ, Vannini V, van Sinderen D, Taranto MP, de Valdez GF, de Giori GS, Sesma F. 2011. B-group vitamin production by lactic acid bacteria\u2014current knowledge and potential applications. J Appl Microbiol 111: 1297\u20131309.","DOI":"10.1111\/j.1365-2672.2011.05157.x"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Clarke G, Sandhu KV, Griffin BT, Dinan TG, Cryan JF, Hyland NP. 2019. Gut reactions: breaking down xenobiotic\u2013microbiome interactions. Pharmacol Rev 71: 198\u2013224.","DOI":"10.1124\/pr.118.015768"},{"key":"14","doi-asserted-by":"publisher","unstructured":"14. Garcia-Gutierrez E, Mayer MJ, Cotter PD, Narbad A. 2019. Gut microbiota as a source of novel antimicrobials. Gut Microbes 10: 1\u201321.","DOI":"10.1080\/19490976.2018.1455790"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Manchanayake LN. 2019. The impact of gut microbiota on host obesity. J Gastrointest Dig Syst 9: 591.","DOI":"10.4172\/2161-069X.1000591"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Trishna S, Vijeev V, Himanshi T. 2018. Gut microbiota in health and disease\u2014an overview. Gastro Med Res 2 (2): GMR.000531.","DOI":"10.31031\/GMR.2018.02.000531"},{"key":"17","unstructured":"17. Treisman GJ. 2017. The role of the brain-gut-microbiome in mental health and mental disorders. <i>In<\/i> The Microbiota in Gastrointestinal Pathophysiology, Floch MH, Ringel Y, Walker WA (eds), Academic Press, Cambridge, pp. 389\u2013397."},{"key":"18","unstructured":"18. Rodr\u00edguez JM, Murphy K, Stanton C, Ross RP, Kober OI, Juge N, Avershina E, Rudi K, Narbad A, Jenmalm MC, Marchesi JR, Collado MC. 2015. The composition of the gut microbiota throughout life, with an emphasis on early life. Microb Ecol Health Dis 26: 26050."},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Aagaard K, Ma J, Antony KM, Ganu R, Petrosino J, Versalovic J. 2014. The placenta harbors a unique microbiome. Sci Transl Med 6: 1\u201322.","DOI":"10.1126\/scitranslmed.3008599"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Lal CV, Travers C, Aghai ZH, Eipers P, Jilling T, Halloran B, Carlo WA, Keeley J, Rezonzew G, Kumar R, Morrow C, Bhandari V, Ambalavanan N. 2016. The airway microbiome at birth. Sci Rep 6: 31023.","DOI":"10.1038\/srep31023"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Dominguez-Bello MG, Costello EK, Contreras M, Magris M, Hidalgo G, Fierer N, Knight R. 2010. Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns. Proc Natl Acad Sci USA 107: 11971\u201311975.","DOI":"10.1073\/pnas.1002601107"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Cabrera-Rubio R, Collado MC, Laitinen K, Salminen S, Isolauri E, Mira A. 2012. The human milk microbiome changes over lactation and is shaped by maternal weight and mode of delivery. Am J Clin Nutr 96: 544\u2013551.","DOI":"10.3945\/ajcn.112.037382"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Hunt KM, Foster JA, Forney LJ, Sch\u00fctte UM, Beck DL, Abdo Z, Fox LK, Williams JE, McGuire MK, McGuire MA. 2011. Characterization of the diversity and temporal stability of bacterial communities in human milk. PLoS One 6: e21313.","DOI":"10.1371\/journal.pone.0021313"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Tanaka M, Nakayama J. 2017. Development of the gut microbiota in infancy and its impact on health in later life. Allergol Int 66: 515\u2013522.","DOI":"10.1016\/j.alit.2017.07.010"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Vall\u00e8s Y, Artacho A, Pascual-Garc\u00eda A, Ferr\u00fas ML, Gosalbes MJ, Abell\u00e1n JJ, Francino MP. 2014. Microbial succession in the gut: directional trends of taxonomic and functional change in a birth cohort of Spanish infants. PLoS Genet 10: e1004406.","DOI":"10.1371\/journal.pgen.1004406"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Fallani M, Young D, Scott J, Norin E, Amarri S, Adam R, Aguilera M, Khanna S, Gil A, Edwards CA, Dor\u00e9 J, Other Members of the INFABIO Team 2010. Intestinal microbiota of 6-week-old infants across Europe: geographic influence beyond delivery mode, breast-feeding, and antibiotics. J Pediatr Gastroenterol Nutr 51: 77\u201384.","DOI":"10.1097\/MPG.0b013e3181d1b11e"},{"key":"27","doi-asserted-by":"publisher","unstructured":"27. Vaishnava S, Yamamoto M, Severson KM, Ruhn KA, Yu X, Koren O, Ley R, Wakeland EK, Hooper LV. 2011. The antibacterial lectin RegIIIgamma promotes the spatial segregation of microbiota and host in the intestine. Science 334: 255\u2013258.","DOI":"10.1126\/science.1209791"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Macpherson AJ, Slack E, Geuking MB, McCoy KD. 2009. The mucosal firewalls against commensal intestinal microbes. Semin Immunopathol 31: 145\u2013149.","DOI":"10.1007\/s00281-009-0174-3"},{"key":"29","doi-asserted-by":"publisher","unstructured":"29. Corfield AP. 2018. The interaction of the gut microbiota with the mucus barrier in health and disease in human. Microorganisms 6: 78.","DOI":"10.3390\/microorganisms6030078"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Hooper LV, Macpherson AJ. 2010. Immune adaptations that maintain homeostasis with the intestinal microbiota. Nat Rev Immunol 10: 159\u2013169.","DOI":"10.1038\/nri2710"},{"key":"31","doi-asserted-by":"publisher","unstructured":"31. Cash HL, Whitham CV, Behrendt CL, Hooper LV. 2006. Symbiotic bacteria direct expression of an intestinal bactericidal lectin. Science 313: 1126\u20131130.","DOI":"10.1126\/science.1127119"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Rea D, Coppola G, Palma G, Barbieri A, Luciano A, Del Prete P, Rossetti S, Berretta M, Facchini G, Perdon\u00e0 S, Turco MC, Arra C. 2018. Microbiota effects on cancer: from risks to therapies. Oncotarget 9: 17915\u201317927.","DOI":"10.18632\/oncotarget.24681"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Jourova L, Anzenbacher P, Anzenbacherova E. 2016. Human gut microbiota plays a role in the metabolism of drugs. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 160: 317\u2013326.","DOI":"10.5507\/bp.2016.039"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Das A, Srinivasan M, Ghosh TS, Mande SS. 2016. Xenobiotic metabolism and gut microbiomes. PLoS One 11: e0163099.","DOI":"10.1371\/journal.pone.0163099"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Grilo NM, Charneira C, Pereira SA, Monteiro EC, Marques MM, Antunes AM. 2014. Bioactivation to an aldehyde metabolite\u2014possible role in the onset of toxicity induced by the anti-HIV drug abacavir. Toxicol Lett 224: 416\u2013423.","DOI":"10.1016\/j.toxlet.2013.10.036"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Jakoby WB, Ziegler DM. 1990. The enzymes of detoxication. J Biol Chem 265: 20715\u201320718.","DOI":"10.1016\/S0021-9258(17)45272-0"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Jeong HG, Kang MJ, Kim HG, Oh DG, Kim JS, Lee SK, Jeong TC. 2013. Role of intestinal microflora in xenobiotic-induced toxicity. Mol Nutr Food Res 57: 84\u201399.","DOI":"10.1002\/mnfr.201200461"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38. Li H, Jia W. 2013. Cometabolism of microbes and host: implications for drug metabolism and drug-induced toxicity. Clin Pharmacol Ther 94: 574\u2013581.","DOI":"10.1038\/clpt.2013.157"},{"key":"39","unstructured":"39. Bosetti C, Boffetta P, La Vecchia C. 2007. Occupational exposures to polycyclic aromatic hydrocarbons, and respiratory and urinary tract cancers: a quantitative review to 2005. Ann Oncol 18: 431\u2013446."},{"key":"40","doi-asserted-by":"crossref","unstructured":"40. Abou-Donia MB, El-Masry EM, Abdel-Rahman AA, McLendon RE, Schiffman SS. 2008. Splenda alters gut microflora and increases intestinal p-glycoprotein and cytochrome p-450 in male rats. J Toxicol Environ Health A 71: 1415\u20131429.","DOI":"10.1080\/15287390802328630"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41. Arboleya S, S\u00e1nchez B, Sol\u00eds G, Fern\u00e1ndez N, Su\u00e1rez M, Hern\u00e1ndez-Barranco AM, Milani C, Margolles A, de Los Reyes-Gavil\u00e1n CG, Ventura M, Gueimonde M. 2016. Impact of prematurity and perinatal antibiotics on the developing intestinal microbiota: a functional inference study. Int J Mol Sci 17: 649.","DOI":"10.3390\/ijms17050649"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42. Francino MP. 2016. Antibiotics and the human gut microbiome: dysbioses and accumulation of resistances. Front Microbiol 6: 1543.","DOI":"10.3389\/fmicb.2015.01543"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43. Korpela K, Salonen A, Virta LJ, Kekkonen RA, Forslund K, Bork P, de Vos WM. 2016. Intestinal microbiome is related to lifetime antibiotic use in Finnish pre-school children. Nat Commun 7: 10410.","DOI":"10.1038\/ncomms10410"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44. Jernberg C, L\u00f6fmark S, Edlund C, Jansson JK. 2007. Long-term ecological impacts of antibiotic administration on the human intestinal microbiota. ISME J 1: 56\u201366.","DOI":"10.1038\/ismej.2007.3"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45. Ford SA, King KC. 2016. Harnessing the power of defensive microbes: evolutionary implications in nature and disease control. PLoS Pathog 12: e1005465.","DOI":"10.1371\/journal.ppat.1005465"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46. van der Waaij D, Berghuis-de Vries JM, Lekkerkerk Lekkerkerk-v . Colonization resistance of the digestive tract in conventional and antibiotic-treated mice. J Hyg (Lond) 69: 405\u2013411.","DOI":"10.1017\/S0022172400021653"},{"key":"47","doi-asserted-by":"crossref","unstructured":"47. Stecher B, Hardt WD. 2008. The role of microbiota in infectious disease. Trends Microbiol 16: 107\u2013114.","DOI":"10.1016\/j.tim.2007.12.008"},{"key":"48","doi-asserted-by":"crossref","unstructured":"48. Bartlett JG, Gerding DN. 2008. Clinical recognition and diagnosis of <i>Clostridium difficile<\/i> infection. Clin Infect Dis 46 Suppl 1: S12\u2013S18.","DOI":"10.1086\/521863"},{"key":"49","doi-asserted-by":"crossref","unstructured":"49. Hapfelmeier S, Hardt WD. 2005. A mouse model for <i>S. typhimurium<\/i>-induced enterocolitis. Trends Microbiol 13: 497\u2013503.","DOI":"10.1016\/j.tim.2005.08.008"},{"key":"50","doi-asserted-by":"crossref","unstructured":"50. Keller JM, Surawicz CM. 2014. <i>Clostridium difficile<\/i> infection in the elderly. Clin Geriatr Med 30: 79\u201393.","DOI":"10.1016\/j.cger.2013.10.008"},{"key":"51","doi-asserted-by":"crossref","unstructured":"51. Ling Z, Liu X, Jia X, Cheng Y, Luo Y, Yuan L, Wang Y, Zhao C, Guo S, Li L, Xu X, Xiang C. 2014. Impacts of infection with different toxigenic <i>Clostridium difficile<\/i> strains on faecal microbiota in children. Sci Rep 4: 7485.","DOI":"10.1038\/srep07485"},{"key":"52","doi-asserted-by":"crossref","unstructured":"52. P\u00e9rez-Cobas AE, Moya A, Gosalbes MJ, Latorre A. 2015. Colonization resistance of the gut microbiota against <i>Clostridium difficile<\/i>. Antibiotics (Basel) 4: 337\u2013357.","DOI":"10.3390\/antibiotics4030337"},{"key":"53","doi-asserted-by":"crossref","unstructured":"53. Voth DE, Ballard JD. 2005. <i>Clostridium difficile<\/i> toxins: mechanism of action and role in disease. Clin Microbiol Rev 18: 247\u2013263.","DOI":"10.1128\/CMR.18.2.247-263.2005"},{"key":"54","doi-asserted-by":"crossref","unstructured":"54. Gao JJ, Zhang Y, Gerhard M, Mejias-Luque R, Zhang L, Vieth M, Ma JL, Bajbouj M, Suchanek S, Liu WD, Ulm K, Quante M, Li ZX, Zhou T, Schmid R, Classen M, Li WQ, You WC, Pan KF. 2018. Association between gut microbiota and <i>Helicobacter pylori<\/i>-related gastric lesions in a high-risk population of gastric cancer. Front Cell Infect Microbiol 8: 202.","DOI":"10.3389\/fcimb.2018.00202"},{"key":"55","doi-asserted-by":"crossref","unstructured":"55. Dunn BE, Cohen H, Blaser MJ. 1997. <i>Helicobacter pylori<\/i>. Clin Microbiol Rev 10: 720\u2013741.","DOI":"10.1128\/CMR.10.4.720"},{"key":"56","doi-asserted-by":"crossref","unstructured":"56. Fischbach W, Malfertheiner P. 2018. <i>Helicobacter pylori<\/i> infection. Dtsch Arztebl Int 115: 429\u2013436.","DOI":"10.3238\/arztebl.2018.0429"},{"key":"57","first-page":"1273","volume":"1","year":"1983","unstructured":"57. Warren JR, Marshall B. 1983. Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet 1: 1273\u20131275.","journal-title":"The Lancet","ISSN":"https:\/\/id.crossref.org\/issn\/0140-6736","issn-type":"print"},{"key":"58","doi-asserted-by":"crossref","unstructured":"58. Kao CY, Sheu BS, Wu JJ. 2016. <i>Helicobacter pylori<\/i> infection: an overview of bacterial virulence factors and pathogenesis. Biomed J 39: 14\u201323.","DOI":"10.1016\/j.bj.2015.06.002"},{"key":"59","doi-asserted-by":"crossref","unstructured":"59. Chang WL, Yeh YC, Sheu BS. 2018. The impacts of <i>H. pylori<\/i> virulence factors on the development of gastroduodenal diseases. J Biomed Sci 25: 68.","DOI":"10.1186\/s12929-018-0466-9"},{"key":"60","unstructured":"60. Shiotani A, Matsumoto H, Fukushima S, Katsumata R, Kawano M, Saito M. 2018. <i>H. pylori<\/i> and human gut microbiota. J Bacteriol Mycol 5: 1086."},{"key":"61","doi-asserted-by":"crossref","unstructured":"61. Andersson AF, Lindberg M, Jakobsson H, B\u00e4ckhed F, Nyr\u00e9n P, Engstrand L. 2008. Comparative analysis of human gut microbiota by barcoded pyrosequencing. PLoS One 3: e2836.","DOI":"10.1371\/journal.pone.0002836"},{"key":"62","doi-asserted-by":"crossref","unstructured":"62. Boutagy NE, McMillan RP, Frisard MI, Hulver MW. 2016. Metabolic endotoxemia with obesity: is it real and is it relevant? Biochimie 124: 11\u201320.","DOI":"10.1016\/j.biochi.2015.06.020"},{"key":"63","doi-asserted-by":"crossref","unstructured":"63. Duncan SH, Belenguer A, Holtrop G, Johnstone AM, Flint HJ, Lobley GE. 2007. Reduced dietary intake of carbohydrates by obese subjects results in decreased concentrations of butyrate and butyrate-producing bacteria in feces. Appl Environ Microbiol 73: 1073\u20131078.","DOI":"10.1128\/AEM.02340-06"},{"key":"64","doi-asserted-by":"crossref","unstructured":"64. Hu Z, Zhang Y, Li Z, Yu Y, Kang W, Han Y, Geng X, Ge S, Sun Y. 2016. Effect of <i>Helicobacter pylori<\/i> infection on chronic periodontitis by the change of microecology and inflammation. Oncotarget 7: 66700\u201366712.","DOI":"10.18632\/oncotarget.11449"},{"key":"65","doi-asserted-by":"publisher","unstructured":"65. Ley RE, Turnbaugh PJ, Klein S, Gordon JI. 2006. Microbial ecology: human gut microbes associated with obesity. Nature 444: 1022\u20131023.","DOI":"10.1038\/4441022a"},{"key":"66","unstructured":"66. Manco M, Putignani L, Bottazzo GF. 2010. Gut microbiota, lipopolysaccharides, and innate immunity in the pathogenesis of obesity and cardiovascular risk. Endocr Rev 31: 817\u2013844."},{"key":"67","doi-asserted-by":"crossref","unstructured":"67. G\u00fclden E, Wong FS, Wen L. 2015. The gut microbiota and type 1 diabetes. Clin Immunol 159: 143\u2013153.","DOI":"10.1016\/j.clim.2015.05.013"},{"key":"68","unstructured":"68. Munro N. 2016. Gut microbiota: its role in diabetes and obesity. Diabetes &amp; Primary Care 18: 1\u20136."},{"key":"69","doi-asserted-by":"crossref","unstructured":"69. Greiner T, B\u00e4ckhed F. 2011. Effects of the gut microbiota on obesity and glucose homeostasis. Trends Endocrinol Metab 22: 117\u2013123.","DOI":"10.1016\/j.tem.2011.01.002"},{"key":"70","doi-asserted-by":"publisher","unstructured":"70. Cani PD, Amar J, Iglesias MA, Poggi M, Knauf C, Bastelica D, Neyrinck AM, Fava F, Tuohy KM, Chabo C, Waget A, Delm\u00e9e E, Cousin B, Sulpice T, Chamontin B, Ferri\u00e8res J, Tanti JF, Gibson GR, Casteilla L, Delzenne NM, Alessi MC, Burcelin R. 2007. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 56: 1761\u20131772.","DOI":"10.2337\/db06-1491"},{"key":"71","doi-asserted-by":"crossref","unstructured":"71. Zheng L, Kelly CJ, Battista KD, Schaefer R, Lanis JM, Alexeev EE, Wang RX, Onyiah JC, Kominsky DJ, Colgan SP. 2017. Microbial-derived butyrate promotes epithelial barrier function through IL-10 receptor\u2013dependent repression of claudin-2. J Immunol 199: 2976\u20132984.","DOI":"10.4049\/jimmunol.1700105"},{"key":"72","doi-asserted-by":"crossref","unstructured":"72. Hague A, Butt AJ, Paraskeva C. 1996. The role of butyrate in human colonic epithelial cells: an energy source or inducer of differentiation and apoptosis? Proc Nutr Soc 55: 937\u2013943.","DOI":"10.1079\/PNS19960090"},{"key":"73","doi-asserted-by":"crossref","unstructured":"73. Zuo T, Ng SC. 2018. The gut microbiota in the pathogenesis and therapeutics of inflammatory bowel disease. Front Microbiol 9: 2247.","DOI":"10.3389\/fmicb.2018.02247"},{"key":"74","unstructured":"74. Morikawa K, Shimazaki T, Takeda R, Izumi T, Umumura M, Sakamoto N, Hepatitis B. 2016. Hepatitis B: progress in understanding chronicity, the innate immune response, and cccDNA protection. Ann Transl Med 4: 337."},{"key":"75","unstructured":"75. Chisari FV. 2000. Rous-Whipple Award Lecture. Viruses, immunity, and cancer: lessons from hepatitis B. Am J Pathol 156: 1117\u20131132."},{"key":"76","doi-asserted-by":"crossref","unstructured":"76. Chou HH, Chien WH, Wu LL, Cheng CH, Chung CH, Horng JH, Ni YH, Tseng HT, Wu D, Lu X, Wang HY, Chen PJ, Chen DS. 2015. Age-related immune clearance of hepatitis B virus infection requires the establishment of gut microbiota. Proc Natl Acad Sci USA 112: 2175\u20132180.","DOI":"10.1073\/pnas.1424775112"},{"key":"77","doi-asserted-by":"crossref","unstructured":"77. Ren YD, Ye ZS, Yang LZ, Jin LX, Wei WJ, Deng YY, Chen XX, Xiao CX, Yu XF, Xu HZ, Xu LZ, Tang YN, Zhou F, Wang XL, Chen MY, Chen LG, Hong MZ, Ren JL, Pan JS. 2017. Fecal microbiota transplantation induces hepatitis B virus e-antigen (HBeAg) clearance in patients with positive HBeAg after long-term antiviral therapy. Hepatology 65: 1765\u20131768.","DOI":"10.1002\/hep.29008"},{"key":"78","doi-asserted-by":"crossref","unstructured":"78. Aly AM, Adel A, El-Gendy AO, Essam TM, Aziz RK. 2016. Gut microbiome alterations in patients with stage 4 hepatitis C. Gut Pathog 8: 42.","DOI":"10.1186\/s13099-016-0124-2"},{"key":"79","doi-asserted-by":"crossref","unstructured":"79. Liu Q, Li F, Zhuang Y, Xu J, Wang J, Mao X, Zhang Y, Liu X. 2019. Alteration in gut microbiota associated with hepatitis B and non-hepatitis virus related hepatocellular carcinoma. Gut Pathog 11: 1.","DOI":"10.1186\/s13099-018-0281-6"},{"key":"80","unstructured":"80. Cassard AM, Ciocan D. 2018. Microbiota, a key player in alcoholic liver disease. Clin Mol Hepatol 24: 100\u2013107."},{"key":"81","doi-asserted-by":"crossref","unstructured":"81. Szabo G. 2015. Gut-liver axis in alcoholic liver disease. Gastroenterology 148: 30\u201336.","DOI":"10.1053\/j.gastro.2014.10.042"},{"key":"82","doi-asserted-by":"crossref","unstructured":"82. Abenavoli L, Falalyeyeva T, Boccuto L, Tsyryuk O, Kobyliak N. 2018. Obeticholic acid: a new era in the treatment of nonalcoholic fatty liver disease. Pharmaceuticals (Basel) 11: 104.","DOI":"10.3390\/ph11040104"},{"key":"83","doi-asserted-by":"crossref","unstructured":"83. Strandwitz P, Kim KH, Terekhova D, Liu JK, Sharma A, Levering J, McDonald D, Dietrich D, Ramadhar TR, Lekbua A, Mroue N, Liston C, Stewart EJ, Dubin MJ, Zengler K, Knight R, Gilbert JA, Clardy J, Lewis K. 2019. GABA-modulating bacteria of the human gut microbiota. Nat Microbiol 4: 396\u2013403.","DOI":"10.1038\/s41564-018-0307-3"},{"key":"84","doi-asserted-by":"crossref","unstructured":"84. Pokusaeva K, Johnson C, Luk B, Uribe G, Fu Y, Oezguen N, Matsunami RK, Lugo M, Major A, Mori-Akiyama Y, Hollister EB, Dann SM, Shi XZ, Engler DA, Savidge T, Versalovic J. 2017. GABA-producing <i>Bifidobacterium dentium<\/i> modulates visceral sensitivity in the intestine. Neurogastroenterol Motil 29: e12904.","DOI":"10.1111\/nmo.12904"},{"key":"85","doi-asserted-by":"crossref","unstructured":"85. Neuman H, Debelius JW, Knight R, Koren O. 2015. Microbial endocrinology: the interplay between the microbiota and the endocrine system. FEMS Microbiol Rev 39: 509\u2013521.","DOI":"10.1093\/femsre\/fuu010"},{"key":"86","doi-asserted-by":"crossref","unstructured":"86. Bravo JA, Forsythe P, Chew MV, Escaravage E, Savignac HM, Dinan TG, Bienenstock J, Cryan JF. 2011. Ingestion of <i>Lactobacillus<\/i> strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve. Proc Natl Acad Sci USA 108: 16050\u201316055.","DOI":"10.1073\/pnas.1102999108"},{"key":"87","doi-asserted-by":"crossref","unstructured":"87. Jiang H, Ling Z, Zhang Y, Mao H, Ma Z, Yin Y, Wang W, Tang W, Tan Z, Shi J, Li L, Ruan B. 2015. Altered fecal microbiota composition in patients with major depressive disorder. Brain Behav Immun 48: 186\u2013194.","DOI":"10.1016\/j.bbi.2015.03.016"},{"key":"88","doi-asserted-by":"crossref","unstructured":"88. Naseribafrouei A, Hestad K, Avershina E, Sekelja M, Linl\u00f8kken A, Wilson R, Rudi K. 2014. Correlation between the human fecal microbiota and depression. Neurogastroenterol Motil 26: 1155\u20131162.","DOI":"10.1111\/nmo.12378"},{"key":"89","doi-asserted-by":"publisher","unstructured":"89. Hsiao EY, McBride SW, Hsien S, Sharon G, Hyde ER, McCue T, Codelli JA, Chow J, Reisman SE, Petrosino JF, Patterson PH, Mazmanian SK. 2013. Microbiota modulate behavioral and physiological abnormalities associated with neurodevelopmental disorders. Cell 155: 1451\u20131463.","DOI":"10.1016\/j.cell.2013.11.024"},{"key":"90","doi-asserted-by":"crossref","unstructured":"90. Kang DW, Adams JB, Coleman DM, Pollard EL, Maldonado J, McDonough-Means S, Caporaso JG, Krajmalnik-Brown R. 2019. Long-term benefit of microbiota transfer therapy on autism symptoms and gut microbiota. Sci Rep 9: 5821.","DOI":"10.1038\/s41598-019-42183-0"},{"key":"91","unstructured":"91. Choi HH, Cho YS. 2016. Fecal microbiota transplantation: current applications, effectiveness, and future perspectives. Clin Endosc 49: 257\u2013265."},{"key":"92","doi-asserted-by":"crossref","unstructured":"92. Sonnenborn U. 2016. <i>Escherichia coli<\/i> strain Nissle 1917-from bench to bedside and back: history of a special <i>Escherichia coli<\/i> strain with probiotic properties. FEMS Microbiol Lett 363: fnw212.","DOI":"10.1093\/femsle\/fnw212"}],"container-title":["Bioscience of Microbiota, Food and Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bmfh\/39\/2\/39_19-023\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,10]],"date-time":"2021-05-10T03:02:16Z","timestamp":1620615736000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bmfh\/39\/2\/39_19-023\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"references-count":92,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.12938\/bmfh.19-023","relation":{},"ISSN":["2186-3342"],"issn-type":[{"value":"2186-3342","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020]]}}}